Diabetes management devices include insulin delivery systems and blood glucose monitoring devices, which are used to treat diabetes effectively and efficiently with fewer side effects. Diabetes (type 1 and type 2) is a chronic disease condition, which occurs due to glucose impairment. The major factors contributing to the disease include obesity, urbanization, sedentary lifestyle, smoking, an elevated level of cholesterols, and hypertension. Vendors in this market are offering high-end insulin delivery systems (less invasive, sleek, pocket-sized, and portable devices) and continuous glucose monitoring systems, which are highly efficient and have user-friendly features.
Diabetes is a chronic disease and is increasing at a rapid pace across the world. It is that state in the body when the pancreas cannot produce sufficient insulin. Increasing blood sugar level can be a threat and can cause severe damage to the body. The study identifies rising global burden of diabetes as one of the primary growth factors for diabetes management devices market. Factors responsible for increase in diabetic population include obesity, smoking, sedentary lifestyle, and growing urbanization. Older people above 65 years are more prone to diabetes. Countries such as China and India have higher diabetic people due to the increase in obesity and urbanization. Owing to the increase in diabetic population across the world, there is increase in adoption of diabetes management devices.
Owing to the presence of several large and small players, the diabetes management devices market is highly competitive. To sustain the competition in the diabetes devices market, the vendors are heavily investing in R&D for designing, developing, and manufacturing innovative products. Currently, the emerging markets across the globe provide huge growth opportunities to the vendors in this marketspace.
The Americas will be the major revenue contributor to the diabetes management devices market throughout the forecast period. Owing to the advancements in technology and the increasing incidence of type 1 and type 2 diabetes, there is an upsurge in the adoption of diabetes management devices in this region.
The global Diabetes Management Devices market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Diabetes Management Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Diabetes Management Devices market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Abbott
Dexcom
F. Hoffmann-La Roche
LifeScan
Medtronic
AgaMatrix
Animas
ARKRAY
Ascensia Diabetes Care
B. Braun Melsungen
BD
Beta Bionics
Bigfoot Biomedical
BIONIME USA
CellNovo
Eli Lilly
iHealth Labs
Insulet
Nemaura Medical
Nipro
Nova Biomedical
Novo Nordisk
Panasonic Healthcare
Prodigy Diabetes Care
Sanofi
Senseonics
Tandem Diabetes Care
Trividia Health
TypeZero Technologies
Valeritas
WellDoc
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Blood glucose monitoring device
Insulin delivery systems
Segment by Application
Hospitals
Clinics and laboratories
Others
Summary:
Get latest Market Research Reports on Diabetes Management Devices. Industry analysis & Market Report on Diabetes Management Devices is a syndicated market report, published as Global Diabetes Management Devices Market Research Report 2019. It is complete Research Study and Industry Analysis of Diabetes Management Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.